BioSpace News Archive

Outlook Therapeutics, Inc. today announced that, following receipt of written confirmation of the NORSE EIGHT proposed clinical trial protocol with the U.S. Food and Drug Administration (FDA), Outlook Therapeutics has submitted a Special Protocol Assessment (SPA) request for the required additional adequate and well-controlled study of ONS-5010.

ProSomnus, Inc., the leading non-CPAP Obstructive Sleep Apnea therapy™, announced the publication of a study by the Cureus Journal of Medical Science, in which the Company’s precision oral appliance therapy devices successfully treated patients’ OSA.

TC BioPharm today announced the pricing of a public offering of 1,750,000 of its American Depositary Shares.

Shorla Oncology today announced the commercial launch of JYLAMVO (methotrexate) oral solution, the first and only oral methotrexate solution approved in the United States for use in adults.

Lipocine Inc. today announced that it will present at the Biotech Showcase and host institutional investor and partnering meetings at this event and at a Corporate Access Event organized by LifeSci Partners.

Aqtual announced today that Gregg C. Fergus has joined as a member of its board of directors.

Altoida announced today results from the RADAR-AD consortium study, published in Nature Digital Medicine, which evaluated its augmented reality (AR) and machine learning (ML)-based digital cognitive assessment for the early identification of individuals with Alzheimer’s Disease (AD).

Boston Pharmaceuticals today announced the appointment of Juan Carlos Lopez-Talavera, M.D., Ph.D., as Acting Chief Medical Officer (CMO).

Intelligent Bio Solutions Inc. today announced that it has received National Association of Testing Authorities (NATA) accreditation for its Intelligent Fingerprinting Drug Screening Solution.

SNP Therapeutics Inc announced today it is launching a line of prenatal nutrition products to complement its Genate™ Test, a prenatal genetic screening test. Genate Prenatal Nutrition will enable women to optimize their nutrition plan based on gene variants associated with nutrient metabolism.